000 01210 a2200325 4500
005 20250518002601.0
264 0 _c20190401
008 201904s 0 0 eng d
022 _a2158-3188
024 7 _a10.1038/s41398-018-0270-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aInkster, Becky
245 0 0 _aGSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?
_h[electronic resource]
260 _bTranslational psychiatry
_c10 2018
300 _a216 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aCognition
_xdrug effects
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aGlycogen Synthase Kinase 3 beta
_xmetabolism
650 0 4 _aHippocampus
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMood Disorders
_xdrug therapy
650 0 4 _aNeuroprotective Agents
_xadministration & dosage
700 1 _aZai, Gwyneth
700 1 _aLewis, Gemma
700 1 _aMiskowiak, Kamilla W
773 0 _tTranslational psychiatry
_gvol. 8
_gno. 1
_gp. 216
856 4 0 _uhttps://doi.org/10.1038/s41398-018-0270-z
_zAvailable from publisher's website
999 _c28928207
_d28928207